Position in DNLI
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$35,744,753
+$10,580,160 QoQ
Shares Held
1,389,765
+6.0% QoQ
Ownership
0.869%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#28
of 290 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 98%
Shared 2%
None 0%
Common Shares in DNLI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NORTHERN TRUST CORP holds $7,813,607,781 across 424 Biotechnology names. DNLI ranks #49 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,486,478 | $1,235,108,212 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
916,467 | $571,453,829 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
886,900 | $266,983,504 | |
| 4 | RPRX |
Royalty Pharma plc
|
4,718,859 | $264,586,419 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
1,117,110 | $209,212,357 | |
| 6 | MRNA |
Moderna, Inc.
|
2,985,329 | $209,062,587 | |
| 7 | INCY |
Incyte Corp
|
1,761,966 | $199,736,460 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,647,345 | $140,337,319 |
All Filings in DNLI
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $35,744,753 | 1,389,765 | Shares | Other | 2026-08-13 | |
| 2026-03-31 | $25,164,593 | 1,310,656 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $19,807,771 | 1,199,744 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $17,920,276 | 1,234,179 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $16,811,906 | 1,201,709 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $15,391,890 | 1,132,173 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $24,486,935 | 1,201,518 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $31,624,750 | 1,085,642 | Shares | Other | 2024-11-13 | |
| 2024-06-30 | $25,146,307 | 1,082,959 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $22,336,285 | 1,088,513 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $23,642,029 | 1,101,679 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $23,038,387 | 1,116,742 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $32,156,986 | 1,089,698 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $23,454,810 | 1,018,004 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $27,370,349 | 984,191 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $27,313,116 | 889,968 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $26,210,885 | 890,618 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $29,153,353 | 906,228 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $42,775,369 | 959,089 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $48,014,525 | 951,725 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $76,797,307 | 979,058 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $43,032,499 | 753,634 | Shares | Other | 2021-05-12 | |
| 2020-12-31 | $65,143,919 | 777,745 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $28,270,513 | 789,018 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $20,124,045 | 832,260 | Shares | Other | 2020-08-14 | |
| 2020-03-31 | $12,225,463 | 698,199 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||